ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1026

Microrna-125a-5p Has Increased Expression in Active Systemic Juvenile Idiopathic Arthritis and Is an Essential Modulator of Regulatory Macrophage Phenotypes in Vitro

Grant Schulert1, Ndate Fall2, Nan Shen3, Sherry Thornton2 and Alexei A. Grom4, 1Pediatric Rheumatology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 2Division of Rheumatology, Cincinnati Children's Hospital, Cincinnati, OH, 3Center for Autoimmune Genomics and Etiology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 4Division of Rheumatology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: macrophage activation syndrome and monocytes, MicroRNA, Systemic JIA

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 8, 2015

Title: Pediatric Rheumatology - Pathogenesis and Genetic

Session Type: ACR Concurrent Abstract Session

Session Time: 4:30PM-6:00PM

Background/Purpose: Systemic juvenile idiopathic arthritis (SJIA) is an autoinflammatory disease of childhood, characterized by a predominance of mononuclear phagocytic effector cells, compared to the lymphocyte driven pathogenesis in other autoimmune JIA subtypes. Monocytes respond to their cytokine milieu by adopting polarization phenotypes with distinct functions, including M1 (classical) activation and several forms of alternative activation, including M2b and M2c which have potent immunoregulatory properties. Previous data has shown that monocytes in SJIA patients have a novel phenotype, with features of both classical activation and immunoregulatory phenotypes. Controlling factors of monocyte/macrophage differentiation in SJIA are unknown. MicroRNAs are transcriptional negative regulators which fine-tune gene expression, and have been implicated in the differentiation of monocytes/macrophages. However, microRNA expression in SJIA has not been examined. 

Methods: CD14+ monocytes were isolated from children with active SJIA and clinically inactive disease (CID), and miRNA expression quantified using TaqMan MicroRNA Array. Primary human monocytes or THP1 macrophage-like cells were polarized using LPS and interferon-γ (M1), IL-4 (M2a), LPS plus immune complexes (M2b), and IL-10 or TGF-β (M2c). THP1 cells were treated with either miR-125a-5p-specific or negative control antagomir or transfected with miR-125a-5p or negative control mimic prior to polarization. Gene expression was determined using real-time PCR or TaqMan assays.  

Results: We identified miR-125a-5p as the most highly upregulated microRNA in monocytes from children with active SJIA compared to those with CID. Expression of miR-125a-5p significantly correlated with markers of disease activity, including serum ferritin and white blood cell count, and systemic features such as rash and hepatomegaly. Expression of miR-125a-5p was significantly increased in both primary human monocytes and THP1 cells after polarization with M2b or M2c conditions, but not by M1 polarization. Interestingly, we found that miR-125a-5p was dispensable for M1 polarization, as treatment with a specific microRNA antagomir did not alter expression of MIG, I-TAC, TNF-α or IL-6. However, miR-125a-5p was essential for M2b polarization, as antagomir treatment significantly reduced expression of the M2b-specific chemokine CCL1 by 56%. Conversely, transfection of miR-125a-5p mimic resulted in enhanced M2b polarization with increased expression of CCL1, IL-6, and CD163. In contrast, miR-125a-5p overexpression diminished M2c polarization, and altered M1 polarization by increasing production of some M2-associated markers.

Conclusion: Our data demonstrated increased miR-125a-5p expression in active SJIA and correlation with disease activity. We also showed that miR-125a-5p serves as an essential regulator of the polarization of M2b regulatory macrophages, and may impact the balance between different forms of alternative activation. Taken together, these data suggest that miR-125a-5p could serve as an important diagnostic and therapeutic target in SJIA.


Disclosure: G. Schulert, None; N. Fall, None; N. Shen, None; S. Thornton, None; A. A. Grom, Novartis Pharmaceutical Corporation, 5,novimmune, 5,Novartis Pharmaceutical Corporation, 2,Roche Pharmaceuticals, 2.

To cite this abstract in AMA style:

Schulert G, Fall N, Shen N, Thornton S, Grom AA. Microrna-125a-5p Has Increased Expression in Active Systemic Juvenile Idiopathic Arthritis and Is an Essential Modulator of Regulatory Macrophage Phenotypes in Vitro [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/microrna-125a-5p-has-increased-expression-in-active-systemic-juvenile-idiopathic-arthritis-and-is-an-essential-modulator-of-regulatory-macrophage-phenotypes-in-vitro/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/microrna-125a-5p-has-increased-expression-in-active-systemic-juvenile-idiopathic-arthritis-and-is-an-essential-modulator-of-regulatory-macrophage-phenotypes-in-vitro/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology